Adapting chromophore-assisted laser inactivation for high throughput functional proteomics

Area of Science:

• Genomics
• Proteomics
• Cellular Biology
• Drug Discovery

Background:

• Genomics and proteomics advances shift research from hypothesis-driven to discovery-driven.
• High-throughput screening is essential for validating numerous gene and protein candidates identified through discovery-based studies.
• Target validation is a critical bottleneck in the early stages of pharmaceutical drug discovery.

Purpose of the Study:

• To highlight the necessity of in situ functional validation technologies for emerging genomic and proteomic discoveries.
• To introduce chromophore-assisted laser inactivation (CALI) as a powerful protein knockdown strategy for target validation.
• To discuss the potential of recent CALI developments for high-throughput applications in hypothesis testing and screening.

Main Methods:

• Utilizing chromophore-assisted laser inactivation (CALI) for direct protein knockdown.
• Applying CALI in a high-throughput manner to test multiple proteins simultaneously.
• Investigating protein and gene function in situ to validate identified targets.

Main Results:

• CALI enables direct testing of specific protein roles in cellular processes.
• Recent advancements allow for high-throughput application of CALI.
• CALI can be used to validate numerous potential targets identified in discovery-based studies.

Conclusions:

• CALI is a powerful tool for target validation in drug discovery.
• High-throughput CALI has significant potential for hypothesis testing and proteome-wide screening.
• CALI addresses the need for functional validation of targets identified through genomics and proteomics.